Nova’s atopic dermatitis (AD) model accounts for the interplay between the skin barrier and the immune system. It describes the key pathways and biomarkers influencing disease course, including the mechanisms driving the immune response dysregulation, the loss of skin barrier integrity and the perturbation of the skin microbiome.
Model description (AD)
Drugs that can be tested
Populations of interest
Possible clinical endpoints
Early insights to optimize your trial design
Combination of treatments
Get your questions answered by downloading the free pdf and learn more about your therapeutic area of interest!